Post-Marketing Surveillance (PMS) Report for Selected Human Medicines Circulating in South Africa 2022/2023

Post-Marketing Surveillance (PMS) Report for Selected Human Medicines Circulating in South Africa 2022/2023

This report displays results of the quality of medicines, including medicines for the treatment of HIV, TB, hyperglycaemia, high blood pressure and hypothyroidism. There are several factors that may lead to medicines not fully complying with quality requirements and specifications. Those factors may include manufacturing processes, transportation, storage, distribution, handling and dispensing to patients.

Download latest version
Document Number: OF-RC-INSP-09E
Version: 2
Date Updated: 06/11/2025
File Type: pdf
Category: Reports
Unit: Regulatory Compliance